LMI-POL-014
Establishes the minimum ethical prerequisites for publishing research involving human participants, identifiable human data or biological material: prior ethics approval or a properly granted waiver, valid informed consent, separate publication consent for identifiable information, safeguards for vulnerable participants and minors, privacy, online and observational research, audits and quality-improvement activity, community-governed research, biobanks, genetics and other sensitive human materials. Defines the journal’s verification role and its limits.
Publisher + Journal Policy
Version 1.0
LMI-POL-015
Establishes minimum requirements for publishing research involving animals: documented prospective ethical oversight under the applicable national and institutional framework, justification of animal use, application of replacement, reduction and refinement, humane care and welfare endpoints, and transparent reporting consistent with recognised animal-research reporting guidance.
Publisher + Journal Policy
Version 1.0
LMI-POL-016
Requires applicable clinical trials to be registered prospectively in a recognised public registry, with the registration number reported and the registry entry consistent with the manuscript. Governs protocol transparency, material deviations and outcome changes, and permits only rare, documented and prominently disclosed exceptions for late registration after an assessment of potential reporting bias.
Publisher + Journal Policy
Version 1.0
LMI-STD-001
Requires each journal to implement design-appropriate reporting guidelines, using current versions and recognised sources such as the EQUATOR Network, while leaving checklist mechanics, submission requirements and enforcement points to journal-level implementation. Clarifies that reporting-guideline compliance improves transparency but does not by itself establish methodological quality.
Journal Implementation Standard
Version 1.0
LMI-POL-017
Establishes how LMI journals identify and handle research whose dissemination could create unusual risk to public health, safety or security — including dual-use research, dangerous pathogen work, and safety-sensitive technical detail. Requires proportionate assessment weighing scientific benefit, foreseeable harm, legal and ethical obligations and possible mitigation, with specialist consultation and publisher escalation, and expressly bars use of the policy to suppress uncomfortable but legitimate research.
Publisher + Journal Policy
Version 1.0